Cryo-EM insight into the structure of MTOR complex 1 and its interactions with Rheb and substrates [version 1; referees: 3 approved]
The mechanistic target of rapamycin (MTOR) is a giant protein kinase that, together with the accessory proteins Raptor and mLst8, forms a complex of over 1 MDa known as MTOR complex 1 (MTORC1). MTORC1, through its protein kinase activity, controls the accretion of cell mass through the regulation of...
Main Authors: | Luke H. Chao, Joseph Avruch |
---|---|
Format: | Article |
Language: | English |
Published: |
F1000 Research Ltd
2019-01-01
|
Series: | F1000Research |
Online Access: | https://f1000research.com/articles/8-14/v1 |
Similar Items
-
mTOR inhibitors in cancer therapy [version 1; referees: 3 approved]
by: Jianling Xie, et al.
Published: (2016-08-01) -
Coordination of Rheb lysosomal membrane interactions with mTORC1 activation [version 1; peer review: 4 approved]
by: Brittany Angarola, et al.
Published: (2020-05-01) -
RNA substrate length as an indicator of exosome interactions in vivo [version 1; referees: 2 approved, 1 approved with reservations]
by: Clémentine Delan-Forino, et al.
Published: (2017-05-01) -
New insights in chemokine signaling [version 1; referees: 3 approved]
by: Daniel F. Legler, et al.
Published: (2018-01-01) -
New insights on the pathogenesis of paraganglioma and pheochromocytoma [version 1; referees: 2 approved]
by: Vitaly Kantorovich, et al.
Published: (2018-09-01)